| ADP | Advanced digital processing |
| ARE | Antioxidant response element |
| ATT | Antitubercular therapy |
| BCA | Bicinchoninic acid |
| CA | Trans-cinnamaldehyde |
| CAT | Catalase |
| CPT | Camptothecin |
| DCFDA | 6-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate |
| DILI | Drug-induced liver injury |
| DMEM | Dulbecco’s minimum essential medium |
| DNA | Deoxyribonucleic acid |
| DTT | Dithiothreitol |
| EMB | Ethambutol |
| HEPES | 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid |
| IC50 | Half maximal inhibitory concentration |
| I/P | A combination of isoniazid and pyrazinamide |
| INH | Isoniazid |
| MAPK | Mitogen-activated protein kinase |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| NLRP3 | NOD-like receptor pyrin domain-containing-3 |
| Nrf2 | Nuclear factor (erythroid-derived 2)-like 2 |
| NQO1 | NAD(P)H quinone dehydrogenase 1 |
| PAGE | Polyacrylamide gel |
| PZA | Pyrazinamide |
| ROS | Reactive oxygen species |
| SDS | Sodium dodecyl sulfate |
| SOD | Superoxide dismutase |
| SU | Sulphoraphane |
| TAMH | Transforming growth factor-α transgenic mouse hepatocytes |
| TBARS | Thiobarbituric acid reactive substances |
| TBHP | Tert-butyl hydroperoxide |
| TCA | Trichloroacetic acid |
| TMRM | Tetramethylrhodamine-methyl-ester |